Clinical Trials Directory

Trials / Completed

CompletedNCT04152187

Effects of Inspiratory Muscle Training in Patients With Pulmonary Hypertension

Investigation of the Effects of Inspiratory Muscle Training in Patients With Pulmonary Hypertension

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Dokuz Eylul University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study aims to determine the possible effects of inspiratory muscle training on cardiovascular, respiratory, physical and psychosocial functions in patients with PH.

Detailed description

Pulmonary Hypertension (PH) is a hemodynamic finding related to increase in pulmonary artery pressure. Because PH disease is a progressive, rare disease, it is important for this disease group to prolong the life span and to increase the quality of life and functional capacity. PH patients have been shown to have weakness in peripheral and respiratory muscles. Patients will be randomly assigned to the inspiratory muscle training and control group. Inspiratory muscle training will be initiated in accordance with the patient at a range of 40-60%. İnspiratory muscle training will be given based on the assessments by the physiotherapist. Patients with PH who come to the routine outpatient clinic and volunteer will be included in the study. The first session will be the evaluation session and the 8-week inspiratory muscle training will be given, the other group will be the control group only. Dyspnoea, diaphragm thickness, pulmonary function, respiratory and peripheral muscle strength, blood pressure, arterial stiffness, physical activity, anxiety, depression and quality of life assessments will be repeated before and after the treatment.

Conditions

Interventions

TypeNameDescription
OTHERInspiratory muscle trainingThe treatment group will receive inspiratory muscle training.

Timeline

Start date
2019-11-11
Primary completion
2022-08-18
Completion
2022-10-18
First posted
2019-11-05
Last updated
2022-11-15

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04152187. Inclusion in this directory is not an endorsement.